- Legislation Introduced to Codify Stem Cell Rules
- Commissioner Enhances FDA’s Commitment to Personalized Medicine
- Perfecting Policy on Stem Cells
- NIH and FDA Aim to Retool Regulatory Science
- DOE Leads Federal Funding for a Regional Innovation Cluster
- Certainty on the Science of Climate Change
- They’re Not Perfect Cells, But They’re Model Cells
- Genomic Medicine on the March
- President’s Budget Aims to Recharge Regional Innovation
- Event: The Science of Climate Change
- Progress in Bioethics
- The Top Science Progress Features of 2009
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
Stem Cells From Embryo Biopsies?
Massachusetts-based Advanced Cell Technology reports that it has grown embryonic stem cells from one cell of an 8-cell embryo left over in a fertility clinic and donated for research, without doing apparent harm to the remaining embryo. If the technique is successful the stem cell lines produced should qualify for federal research funding under President Bush’s policy. However, some doubt remains about the actual consequences for the embryo. Although the embryo biopsy technique has been used in fertility treatments for genetic testing, studies of the actual effects on pregnancy are disputed. Without definitive evidence of safety for the original embryo the administration’s policy seems unlikely to change, according to The Washington Post.
The company received criticism in 2006 for announcing that they had established this technique, but at the time they had not allowed the remaining embryos to be cultured to see if, indeed, they appeared to be normal. This time they went through the process of ensuring that the normal tissues were apparently created by the embryos as they divided.
The uncertainty about damage to the embryo from this biopsy procedure that is used in the private sector is partly due to a lack of federally supported research on in vitro fertilization, a decision made 1980 by the Reagan administration. Ironically, a decision made over 25 years ago out of concern about research involving human embryos now appears to threaten one pathway to alternatives to research that destroys human embryos. (I have previously written about this problem with stem cell biologist John Gearhart.)
Besides the safety issue, some opponents of human embryonic stem cell research object that the single-cell biopsy concept is ethically flawed because the single cell that is removed at the 8-cell stage might itself have the potential to form an embryo under the right conditions.
Comments on this article
